012980000a22002890004500003000900000005001700009110013300026245014300159562003000302264006700332490004100399300000900440090003600449041000800485590000800493650006400501650002300565650003400588650003700622650003000659650002800689700007900717890006900796942000800865999001500873952012000888PH-MaWHO20241108112402.0  aConsultation Meeting on Improving Access to Essential Medicines in the Western Pacific Region (2003 : Penang, Malaysia).9659170  aConsultation Meeting on Improving Access to Essential Medicines in the Western Pacific Region, Penang, Malaysia, 15-17 July 2003 : report.  a(WP)PHA/ICP/HRF/5.1/001-E  aManila : bWHO Regional Office for the Western Pacific,c2003.  a(Reprot series; no.RS/2002/GE/9(MAA)  a41p.  aWPRO File (Reports of Meetings)  aeng  aHRF  aEssential drugsxStandards, supply and distribution9659171  aDrug costs9386865  aCost-benefit analysis9119335  aNational health programs9243943  aStrategic planning910408  aWestern Pacific9645911  aWorld Health Organization. Regional Office for the Western Pacific9645996  uhttp://whqlibdoc.who.int/wpro/2003/(WP)PHA_ICP_HRF_5.1_001-e.pdf  cDOC  c9065d9065  00104070aWPRObWPROd2021-05-23l0oWPRO File (Reports of Meetings)p09065r2024-01-24 00:00:00w2021-05-23yDOC